EE374 Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.1973
https://www.valueinhealthjournal.com/article/S1098-3015(25)02102-3/fulltext
Title :
EE374 Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)02102-3&doi=10.1016/j.jval.2025.04.1973
First page :
Section Title :
Open access? :
No
Section Order :
10154